Pharma and Healthcare
-
From Data to Diagnosis: How Precision Medicine is Creating New Opportunities for GCCs
Precision medicine is transforming healthcare by enabling treatments tailored to an individual’s genetic profile, clinical history, and lifestyle. At the…
Read More » -
From Enablers to Innovators: The Future of Life Sciences GCCs
EY recently published its thought leadership paper, Reimagining Life Sciences Global Capability Centers, which explores how GCCs are reshaping the…
Read More » -
Product Development Set to Leap Ahead for Pharma GCCs
Traditional drug discovery—combining chemicals, testing in labs, and conducting animal and human clinical trials—has been slow and resource-intensive. Only a…
Read More » -
Pharma GCCs: Driving Innovation Beyond Drug Development
Global Capability Centers (GCCs) in the pharmaceutical industry have evolved significantly over the past decade. Once primarily focused on back-office…
Read More »